Rates of both acute and chronic complications significantly increase with increasing HbA1c.
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Risk factors for developing atrial fibrillation similar to those seen for other forms of cardiovascular disease.
However, benefits were not sustained 12 months after completion of the intervention.
Individuals who tend to experience negative affect and diabetes distress before eating are at increased risk for objective binge eating at an upcoming meal.
Women whose HbA1c levels were consistent with target values also at increased risk for preterm birth.
Pediatric patients with poorly controlled type 1 diabetes consider home-based video visits with healthcare providers to be feasible and satisfactory.
Introduction of the oral rotovirus vaccine in Australia was associated with a decline in the incidence of type 1 diabetes.
Investigators examine characteristics associated with disordered eating behaviors in teenagers with type 1 diabetes.
Fracture risk up with T2DM and current use of rosiglitazone, pioglitazone regardless of glycemic control.
The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with up-to-date recommendations.
Treatment of thyroid disease, severe infections, glucagon prescriptions, and diabetic retinopathy occur more frequently in individuals with type 1 diabetes who are subsequently diagnosed with Addison disease.
Type 1 diabetes predisposes children and adults to autoimmune diseases, which can impair glucose metabolism and interfere with insulin therapy.
The effect of high-intensity interval training with a bout of moderate-intensity continuous training on glucose levels was examined in T1D.
Day-and-night hybrid closed-loop insulin delivery improves glucose control compared with sensor-augmented pump therapy.
Repeated exposure to high levels of HbA1c was associated with increased risk for dementia in a cohort of patients age ≥50 with type 1 diabetes.
WHO has developed guidelines for selecting therapy for treatment intensiﬁcation in type 2 diabetes and on the use of insulin in type 1 and 2 diabetes in resource-poor settings.
Researchers found that patients with T1DM and poor glycemic control were more frequently diagnosed with infections.
Excess risk differed by up to 5 times across different diagnosis age groups.
The PedsQL 3.2 can assist in identify new and existing therapeutic interventions for individuals with different diabetes-specific health-related quality of life profiles.